ORIGONI, MASSIMO
 Distribuzione geografica
Continente #
EU - Europa 3.214
AS - Asia 3.003
NA - Nord America 2.065
SA - Sud America 795
AF - Africa 59
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.142
Nazione #
US - Stati Uniti d'America 1.971
RU - Federazione Russa 1.802
SG - Singapore 1.147
CN - Cina 975
BR - Brasile 648
SE - Svezia 415
IT - Italia 408
HK - Hong Kong 326
VN - Vietnam 282
FR - Francia 145
DE - Germania 102
GB - Regno Unito 77
IN - India 62
AR - Argentina 55
BD - Bangladesh 48
FI - Finlandia 48
CA - Canada 39
NL - Olanda 36
MX - Messico 35
EC - Ecuador 30
ID - Indonesia 29
PL - Polonia 28
ES - Italia 26
PT - Portogallo 26
ZA - Sudafrica 26
AT - Austria 25
IE - Irlanda 24
JP - Giappone 24
TR - Turchia 20
CO - Colombia 19
IQ - Iraq 19
PY - Paraguay 17
CL - Cile 11
PK - Pakistan 10
MA - Marocco 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
UA - Ucraina 8
UZ - Uzbekistan 8
AL - Albania 6
IL - Israele 6
LT - Lituania 6
SA - Arabia Saudita 6
CH - Svizzera 5
CR - Costa Rica 5
MY - Malesia 5
PE - Perù 5
PH - Filippine 5
TN - Tunisia 5
AU - Australia 4
DZ - Algeria 4
EG - Egitto 4
NG - Nigeria 4
VE - Venezuela 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
IR - Iran 3
JM - Giamaica 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
BE - Belgio 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
EU - Europa 1
GF - Guiana Francese 1
GY - Guiana 1
IS - Islanda 1
KG - Kirghizistan 1
KR - Corea 1
LV - Lettonia 1
MD - Moldavia 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 9.142
Città #
Singapore 467
Moscow 356
Ashburn 355
Hong Kong 322
Dallas 280
San Jose 251
Shanghai 167
Hefei 145
Beijing 141
Lawrence 135
Princeton 135
Lauterbourg 117
Ho Chi Minh City 112
Milan 93
New York 78
Hanoi 63
São Paulo 61
Los Angeles 50
Boardman 42
Helsinki 35
Orem 31
Santa Clara 27
Nuremberg 25
Rio de Janeiro 25
Rome 24
Tokyo 24
Dublin 23
Johannesburg 19
Munich 19
Chennai 18
Porto 18
Pune 18
Warsaw 18
Bologna 17
Da Nang 17
London 16
Denver 15
Guangzhou 15
Atlanta 14
Belo Horizonte 14
Brooklyn 14
Chicago 14
Frankfurt am Main 14
Manchester 14
Brasília 13
Naples 13
Guayaquil 12
Haiphong 12
Boston 11
Houston 11
Montreal 11
Poplar 11
Mexico City 10
Vienna 10
Washington 10
Amsterdam 9
Ankara 9
Council Bluffs 9
Nanjing 9
Phoenix 9
Porto Alegre 9
Querétaro 9
Tianjin 9
Turku 9
Campinas 8
Hải Dương 8
Islington 8
Ribeirão Preto 8
Sorocaba 8
Stockholm 8
Tashkent 8
Baghdad 7
Bari 7
Buenos Aires 7
Guarulhos 7
New Delhi 7
Seattle 7
Surabaya 7
Bergamo 6
Carpineto Romano 6
Catania 6
Columbus 6
Contagem 6
Cortona 6
Curitiba 6
Dubai 6
Juiz de Fora 6
Piracicaba 6
Salvador 6
The Dalles 6
Tirana 6
Toronto 6
Turin 6
Asunción 5
Cape Town 5
Genoa 5
Ha Long 5
Nova Iguaçu 5
Novara 5
Quito 5
Totale 4.293
Nome #
5-Hydroxytyrosol inhibits HIV-1 replication in primary cells of the lower and upper female reproductive tract 133
Long-Term Follow-Up Outcomes in Women with In Situ/Microinvasive Adenocarcinoma of the Uterine Cervix Undergoing Conservative Treatment—Cervical Adenocarcinoma Study Group Italian Society of Colposcopy and Cervico-Vaginal Pathology 128
The Peritoneal Neovagina after Davydov's Laparoscopic Procedure in Mayer-Rokitansky-Küster-Hauser Syndrome: Morphology and Ultrastructure Investigation of the New Epithelium 128
HPV Opportunistic Vaccination: A Literature Review and a Single-Center Experience in Northern Italy through the COVID-19 Pandemic 120
Surgical approaches to in-utero spina bifida repair: a Systematic Review 120
Hysterectomy for cervical intraepithelial neoplasia: A retrospective observational multi-institutional study 117
Papillomavirus umano (HPV) con associata Sindrome della Vestibolite Vulvare e papillomatosi vestibolare 110
Bombelli - Castiglioni Ginecologia e Ostetricia 110
[HPV vaccination: not only female adolescents and not only prophylactic. Review and position paper of the Italian HPV Study Group (IHSG)] 110
Colposcopy Accuracy and Diagnostic Performance: A Quality Control and Quality Assurance Survey in Italian Tertiary-Level Teaching and Academic Institutions—The Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV) 107
Cervical Cancer Prevention: New Frontiers of Diagnostic Strategies 106
An alternative approach for the treatment of vaginal atrophy 104
Clinicopathologic analysis of 370 cases of vulvar intraepithelial neoplasia - Italian Study Group on vulvar disease 104
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study 103
Botulinum toxin injection in vulva and vagina. Evidence from a literature systematic review 102
Antigens of the HLA system in women with vulvar lichen sclerosus. Association with HLA-B21 99
Caesarean section: a woman's right? 99
Citologia, colposcopia, istologia ed ibridazione molecolare nella diagnosi di infezione cervicale da HPV: studio comparativo 99
"Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3 99
Prognostic Significance of Neutrophil/Lymphocytes Ratio (NLR) in Predicting Recurrence of Cervical Dysplasia 95
Acute isolated tubal torsion in pregnancy due to twisted Morgagni hydatid 94
Cervical Human papillomavirus in transplanted Italian women: a long-term prospective follow-up study. 94
Candidate Microbicide 5-hydroxytyrosol (5-HT) Inhibits Productive R5 HIV-1 Infection of Human Cervical Tissue Explants (CTE). 93
Antigens of HLA system in patients with vulvar lichen sclerosus 93
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study 91
Postmenopausal vulvovaginal atrophy (VVA) is positively improved by topical hyaluronic acid application. A prospective, observational study 90
TERAPIA DELLA SM CON FARMACI BIOLOGICI: la questione HPV 90
CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix 89
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement 89
An unusual diagnosis of primary Non-Hodgkin lymphoma of the vagina stage IE 83
Low-Malignant Schwannoma of the Cervix in Pregnancy: A Case Report and Literature Systematic Review 81
An oral component: vaginal lesions were associated with gingival symptoms 80
Cervical Intraepithelial Neoplasia (CIN) in pregnancy: the state of the art 77
Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva Stage III and IVA FIGO 76
Incidenza, indicazioni e orientamenti dell'isterectomia ostetrica 75
Results from an Italian consensus conference on prevention and management of infections in MS patients treated with biological and non biological disease modifying drugs 73
Spontaneous regression of low-grade cervical intraepithelial lesions is positively improved by topical bovine colostrum preparations (GINEDIE®). A multicentre, observational, italian pilot study 72
Progetto SOPHY: Studio osservazionale sul pH vaginale e sullo stile di vita della donna nelle diverse età e condizioni fisiopatologiche. Parte I 72
Topical testosterone in the treatment of vulvar lichen sclerosus 72
Prognostic value of pathological patterns of lymphnode positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO 71
Lesioni squamose intraepiteliali della cervice uterina (SIL): tipizzazione e significato prognostico dei genotipi di HPV 70
La sindrome ab ingestis in corso di taglio cesareo: incidenza e condotta terapeutica 70
La diagnostica strumentale e di laboratorio in oncologia ginecologica 70
Results from an italian Consensus Conference on prevention and management of infections in multiple sclerosis patients treated with biological and non biological disease modifying drugs 70
Monitoring the activities of Italian colposcopy clinics before and during the COVID-19 pandemic 68
Topical testosterone in the treatment of vulvar Lichen Sclerosus 67
Il prurito vulvare non va sottovalutato 67
Worsening immunodeficiency correlates with increasing frequency of HPV-correlated cervical intraepithelial lesions in HIV-infected women 67
TOPICAL TESTOSTERONE IN THE TREATMENT OF VULVAR LICHEN-SCLEROSUS 66
SOPHY project: an observational study of vaginal PH, lifestyle and correct intimate hygiene in women of different physiopathological conditions. Part II 65
Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy 65
E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): A promising perspective 64
Melanoma of the vulva: A pathologic study of 8 cases 64
Topical testosterone in the treatment of vulvar lichen sclerosus 64
Spontaneous post-cesarean regression of massive cervico-vaginal condylomatosis in pregnancy 64
I fattori di rischio per il tumore invasivo della vulva 64
I nuovi biomarcatori: p16INK4a e Ki-67 (CINtec PLUS) 62
Fractional CO2 laser improves sexual function in women with vulvovaginal atrophy 61
Sebaceous glands in the uterine portio. A report of two cases 61
In Situ/Microinvasive Adenocarcinoma of the Uterine Cervix and HPV-Type Impact: Pathologic Features, Treatment Options, and Follow-Up Outcomes—Cervical Adenocarcinoma Study Group (CAS-Group) 60
Spinocellular carcinoma of the vulva. Critical review of the surgical case histories from 1967-1989 60
Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women 60
Micropapillomatosi del vestibolo vulvare e HPV: indagine biomolecolare su prelievo citologico: risultati preliminari 60
Vascular endothelial growth factor - Expression in human vulvar neoplastic and nonneoplastic tissues 59
Topical oxatomide: An alternative approach for the treatment of vulvar lichen sclerosus 59
Efficacy of topical oxatomide in women with pruritus vulvae 59
Splenic hamartoma in pregnancy 59
DETERMINANTS OF INVASIVE VULVAR CANCER RISK - AN ITALIAN CASE-CONTROL STUDY 59
Test HPV e prevenzione della carcinoma della cervice uterina - Dalle evidenze alla clinica. Guida Pratica 2010 59
Valuable expression of MIB1 index in serous ovarian tumors 58
Protein S100 and cytokeratins A,B,C in vulvar lichen sclerosus: immunohistochemical study 58
Gynecologic and Obstetric Surgery 58
Proposal of a Risk Stratification Model for Recurrence After Excisional Treatment of High-Grade Cervical Intraepithelial Neoplasia (HG-CIN) 57
Goserelin depot therapy for heavy dysfunctional uterine bleeding in severely anemic women 57
Vaginal Surgery - Fourth Edition 57
The coexistence of HPV16 and 18 related high grade intraepithelial neoplasia and microinvasive endocervical adenocarcinoma 57
HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice 57
Extralesional detection and load of human papillomavirus DNA: a possible marker of preclinical tumor spread in cervical cancer 56
Therapy of vulvar lichen sclerosus: testosterone vs. placebo. A randomized study 55
High frequency of normal karyotypes in endometrial adenocarcinomas 55
Preneoplastic lesions of the vulva 55
Extending Human Papillomavirus (HPV) vaccination beyond female adolescents and after treatment for high grade CIN: the Italian HPV Study Group (IHSG) review and position paper 55
Human papillomavirus with co-existing vulvar vestibulitis syndrome and vestibular papillomatosis 53
Esiti riproduttivi dopo chirurgia conservativa ovarica per neoplasie "borderline malignancy" 53
Microablative fractional CO2 laser improves dyspareunia related to vulvovaginal atrophy: A pilot study 53
Vulvar dystrophies: diagnostic problems and therapeutic indications 53
Malattie della vulva e della vagina 53
Il trattamento con testosterone topico nel lichen scleroso vulvare 53
Prognostic factors in patients with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy 52
Human papillomavirus DNA and pap tests: The need for cotesting in opportunistic setting during the transition time 52
NEURAL BLOCKADE UNDER NEUROPHYSIOLOGICAL GUIDANCE FOR CHRONIC PELVIC PAIN IN 110 WOMEN AFFECTED BY PUDENDAL NEURALGIA (PN) 52
Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma 52
Transvaginal sonography in persistent gestational trophoblastic tumor (GTT) 52
Small Cell Carcinoma of the Ovary: Report of Three Cases of a Poor Prognosis Disease 51
Lichen sclerosus of the vulva 51
Microscopic and ultrastructural modifications of postmenopausal atrophic Vaginal mucosa after fractional carbon doixide laser treatment 51
Serous borderline-malignancy tumors of the ovary 51
Efficacy of topical oxatomide in vulvar lichen sclerosus: A prospective randomized study 50
HPV-DNA test: indicazioni e strategie di utilizzo. in: APOG Aggiornamento Permanente in Ostetricia e Ginecologia 50
Gestione della paziente con pap test anormale. Linee Guida SICPCV 2006 50
Totale 7.358
Categoria #
all - tutte 59.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.758


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 0 46 8 16 12 12 9 11 14 10
2022/2023762 313 172 41 2 3 89 33 50 33 7 5 14
2023/2024412 16 45 44 89 17 55 22 26 6 12 23 57
2024/20251.809 228 21 30 72 58 134 289 155 339 158 166 159
2025/20266.056 457 545 404 949 457 194 521 431 1.623 285 114 76
Totale 9.205